Research in cancer treatment
NBE-Therapeutics has raised €62M across 4 funding rounds from 3 investors, most recently a Series C round in Oct 2020. Based in Basel, Switzerland; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-10-01 | Series C | €19M | Boehringer Ingelheim,PPF Group | View deal → |
| 2020-09-10 | Other | €21M | — | View deal → |
| 2016-11-01 | Series B | €19M | Boehringer Ingelheim Venture Fund,PPF Group | View deal → |
| 2015-03-01 | Series A | €2.8M | Boehringer Ingelheim Venture Fund | View deal → |
